Top Tweets for #ESHCML2020
Orgulloso de haber podido participar, y tener video-encuentros en grupos pequeños, pudiendo conversar con los expertos mundiales en #LMC más reconocidos.
#ESHCML2020
@cmlnet
The CML Newsletter - October 2020 is released!
Find out more about our members' activities on #WCMLDay20, the "Voices of CML" regional sessions on Youtube, or our advocacy actions presenting results of the #TFR4CML study at #ESHCML2020.
https://t.co/cRsr9yzpIO
#PatientAdvocacy
#ESHCML2020 concluded yesterday. A very successful meeting, great science and discussion. Thank you all who participated. We will see you next year in Mandelieu, France, October 1-3, 2021 for the 23rd edition of the John Goldman E-Conference on CML: Biology and Therapy.
One of the highlights of this year’s Goldman Conference on CML. If you missed it, go the the recorded program on demand available in the main Lecture Hall, on the E-Conference platform for another 10 days. #ESHCML2020
Congratulations to Jane Apperley from Imperial College London, on receiving the John Goldman Prize during #ESHCML2020 for lifetime contributions to clinical research, improving lives of patients with CML. Well deserved recognition for a lifetime of very valuable CML research.
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
#CML:
DEBATE: “SWITCH TO A MORE POTENT DRUG TO GAIN ELIGIBILITY FOR #TFR?”
Chair: Philippe Rousselot
Against: Charles Schiffer
For: Giuseppe Saglio
October 4, 2020
#iCMLf #ESHCML2020 #LMC
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
#CML:
DEBATE: “SWITCH TO A MORE POTENT DRUG TO GAIN ELIGIBILITY FOR #TFR?”
Chair: Philippe Rousselot
Against: Charles Schiffer
For: Giuseppe Saglio
October 4, 2020
#iCMLf #ESHCML2020 #LMC
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
#CML:
DEBATE: “SWITCH TO A MORE POTENT DRUG TO GAIN ELIGIBILITY FOR #TFR?”
Chair: Philippe Rousselot
Against: Charles Schiffer
For: Giuseppe Saglio
October 4, 2020
#iCMLf #ESHCML2020 #LMC
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
#CML:
DEBATE: “SWITCH TO A MORE POTENT DRUG TO GAIN ELIGIBILITY FOR #TFR?”
Chair: Philippe Rousselot
Against: Charles Schiffer
For: Giuseppe Saglio
October 4, 2020
#iCMLf #ESHCML2020 #LMC
@cmlnet @sehh_es @SEHHJoven @espGELMC
@cmlnet @AndreasHochhaus @mjmauroMD @GioraSharf @LMC_PACIENTES @ESHaematology Learning from the #CML experts!
Amazing discussion: "Understanding and analyzing ELN recommendations"
#TFR management, #CML #patients goals, expectations, #clinicaltrials, #COVID19 impact on monitoring...
Thanks! #ESHCML2020 @ESHaematology
Today attending #ESHCML2020 "Meet-the-Expert Session - Andreas Hochhaus @AndreasHochhaus and Michael Mauro @mjmauroMD with the participation of 4 #CML #PatientAdvocates: our co-founders Jana Pelouchova & Giora Sharf @GioraSharf + @LMC_PACIENTES & @CMRancel
@ESHaematology #CML
We had another great day at #ESHCML2020, with great talks. Join tomorrow for the conclusion with a workshop on artificial intelligence, a debate on switching therapy to achieve DMR, talks on TKI safety, and presentation of iCMLf Award. https://t.co/bsul48AhaL
Comparison between the CML Advocates Network regions about discussed topics when considering stopping treatment.
Risks and benefits of stopping
Drug withdrawal symptoms
Timing
#ESHCML2020 #TFR4CML #TFR #CML
@GioraSharf @ESHaematology
“Scientific session 7: #TFR predictive factors” Experts discussion.
#ESHCML2020 #CML @ESHaematology
@GioraSharf @GCC_Cortes @timhughesCML @DelphineGRea
#TFR4CML
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
Q&A time¡¡¡
Great panelists group¡¡¡
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
Lack of communication between #CML #patients on #TFR and doctors: Information they would liked to have received:
1. Results of #TreatmentFreeRemission #clinicaltrials
2. TFR steps
3. Risks & opportunities
#ESHCML2020 @GioraSharf #TFR4CML @ESHaematology
22nd ANNUAL JOHN GOLDMAN E-CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
TREATMENT-FREE REMISSION - PREDICTIVE FACTORS
October 3, 2020
#iCMLf #ESHCML2020 #LMC
@DelphineGRea #Yong #Kim @GioraSharf #Millot
@cmlnet @sehh_es @SEHHJoven @espGELMC
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.6M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers